Urogen Pharma(DE:UR8)
€23.35+0.06 (+0.26%)
DE:UR8
Urogen Pharma earnings date
€23.35
At close:+0.06 (+0.26%)
Urogen Pharma (UR8) Q2 2026 Earnings Report
1 Followers
DE:UR8 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.25
- Consensus EPS
- -EUR 0.24
- Beat/Miss
- Missed by -EUR 0.01
- One Year Ago EPS
- -EUR 0.94
DE:UR8 Q2 2026 Revenue Results
- Actual Revenue
- EUR 64.87M
- Expected Revenue
- EUR 56.90M
- Beat/Miss
- Beat by +EUR 7.98M
- YoY Revenue Growth
- +199.22%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/05/2026
- Time
- Before Open
- Conference Call
- Wednesday, August 5, 2026
DE:UR8 Upcoming Earnings
Urogen Pharma's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:UR8 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UR8 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | 0.35- | -0.48 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 0.09-0.03 | -0.62 | 95.65% (+0.59) | |
| Aug 05, 2026 | 2026 (Q2) | -0.24-0.25 | -0.94 | 73.33% (+0.69) | |
| May 06, 2026 | 2026 (Q1) | -0.43-0.42 | -0.82 | 48.91% (+0.40) | |
| Mar 02, 2026 | 2025 (Q4) | -0.45-0.48 | -0.72 | 32.50% (+0.23) | |
| Nov 06, 2025 | 2025 (Q3) | -0.62-0.62 | -0.49 | -25.45% (-0.13) | |
| Aug 07, 2025 | 2025 (Q2) | -0.77-0.94 | -0.81 | -15.38% (-0.13) | |
| May 12, 2025 | 2025 (Q1) | -0.72-0.82 | -0.87 | 5.15% (+0.04) | |
| Mar 10, 2025 | 2024 (Q4) | -0.64-0.72 | -0.64 | -11.11% (-0.07) | |
| Nov 06, 2024 | 2024 (Q3) | -0.73-0.49 | -0.61 | 19.12% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
